HOME >> MEDICINE >> NEWS
A nicotine by-product reacts with proteins, say scientists at TSRI

the development of these advanced glycation endproducts.

When they tested the blood of smokers and non-smokers, they found that the smokers had higher levels of the nornicotine-modified proteins than non-smokers. The smokers also had higher levels of the advanced glycation endproducts.

The persistence of nornicotine in the bloodstreamas opposed to nicotine, which quickly disappears after cessation of smokingmay also suggest a role for nornicotine in contributing to the biological mechanisms of tobacco addiction, since the nornicotine provides a long-lived source of nicotine-like molecules.

The work highlights the need for more studies into the consequences of exposing the human body to nicotine metabolites, like nornicotine.

The article, "A previously undescribed chemical link between smoking and metabolic disease" was authored by Tobin J. Dickerson and Kim D. Janda and appears in the October 28, 2002 online edition of the journal Proceedings of the National Academy of Sciences. The article will appear in print later this year.


'"/>

Contact: Jason Bardi
jasonb@scripps.edu
858-784-9254
Scripps Research Institute
28-Oct-2002


Page: 1 2

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Brain activity of men and women during hostile or impulsive acts differs less on nicotine
3. Animal study shows link between nicotine and atrial flutter
4. Free nicotine patches increase short-term smoking quit rates
5. Brains nicotine receptors also target for anti-depressants
6. Antidepressant may help people stop smoking when used with nicotine patch
7. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
8. Reduced exposure tobacco products lessen carcinogen exposure, but medicinal nicotine better
9. Success of nicotine patches linked to genetic make-up
10. Study supports new theory for nicotines protective effect against neurodegenerative disorders
11. Minors able to buy nicotine replacement therapy products

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... 28, 2017 , ... Guide to FDA and EU Medical Device Regulations: 2017 ... side of the Atlantic devicemakers do business, this fully updated and expanded guide keeps ... addition to the full text of the FDA’s regulations in 21 CFR Parts 800 ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... David B. Sosin, a founding ... Illinois, took over the post of 2nd Vice President for the Illinois State Bar ... installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... 2017 , ... Harbour , a DAO (decentralized autonomous organization) that harnesses ... released their technical specifications . , 2017 has seen an explosion of token ... determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ... Joseph R. Goodwin , U.S. District Court Judge ... , entered a case management order in MDL ... Liability Litigation (the "MDL") that includes a provision requiring ... disclosures on specific causation within one hundred twenty (120) ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology:
Cached News: